Haoyang Lu
- Biological Psychiatry top 5%
- Tryptophan and brain disorders 6
- Pharmaceutical Science top 5%
- Behavioral Neuroscience top 10%
- Psychiatry and Mental health top 10%
- Bipolar Disorder and Treatment 7
- Schizophrenia research and treatment 5
- Epilepsy research and treatment 5
- Pharmacology top 10%
- Pharmacogenetics and Drug Metabolism 8
- Treatment of Major Depression 4
-
- Gut microbiota and health 4
-
- Pharmacological Effects and Toxicity Studies 4
- Journals
- Frontiers in Pharmacology (5 papers)Human Psychopharmacology Clinical and Experimental (3 papers)Xenobiotica (3 papers)
- Partner nations
- ChinaUnited States
In The Last Decade
Haoyang Lu
41 papers receiving 664 citations
Peers
Comparison fields: 5 of 126
- Biological Psychiatry 102
- Pharmaceutical Science 126
- Behavioral Neuroscience 39
- Psychiatry and Mental health 93
- Pharmacology 45
Countries citing papers authored by Haoyang Lu
This map shows the geographic impact of Haoyang Lu's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Haoyang Lu with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Haoyang Lu more than expected).
Fields of papers citing papers by Haoyang Lu
This network shows the impact of papers produced by Haoyang Lu. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Haoyang Lu. The network helps show where Haoyang Lu may publish in the future.
Co-authorship network
The 25 scholars most cited alongside Haoyang Lu, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2025 | 4 | |
| 2 | 2025 | 0 | |
| 3 | 2024 | 4 | |
| 4 | 2024 | 6 | |
| 5 | 2024 | 0 | |
| 6 | 2024 | 0 | |
| 7 | 2023 | 3 | |
| 8 | 2023 | 1 | |
| 9 | 2022 | 6 | |
| 10 | 2022 | 8 | |
| 11 | 2021 | 7 | |
| 12 | 2021 | 31 | |
| 13 | 2021 | 71 | |
| 14 | 2020 | 46 | |
| 15 | 2019 | 15 | |
| 16 | 2018 | 24 | |
| 17 | 2018 | 7 | |
| 18 | 2016 | 66 | |
| 19 | 2015 | 11 | |
| 20 | 2014 | 93 |
About Haoyang Lu
Haoyang Lu is a scholar working on Biological Psychiatry, Pharmacology and Psychiatry and Mental health, having authored 47 papers that have together received 676 indexed citations. Recurring topics across this work include Pharmacogenetics and Drug Metabolism (8 papers), Bipolar Disorder and Treatment (7 papers), Tryptophan and brain disorders (6 papers), Schizophrenia research and treatment (5 papers), Epilepsy research and treatment (5 papers), Gut microbiota and health (4 papers), Pharmacological Effects and Toxicity Studies (4 papers) and Treatment of Major Depression (4 papers). The work is most often cited by research in Biological Psychiatry (102 citations), Pharmaceutical Science (126 citations) and Behavioral Neuroscience (39 citations). Haoyang Lu has collaborated with scholars based in China and United States. Frequent co-authors include Dewei Shang, Xiaojia Ni, Yuguan Wen, Chuanbin Wu, Yuehong Xu, Zhanzhang Wang, Jinqing Hu, Shuhua Deng, Shanqing Huang and Xiuqing Zhu. Their work appears in journals such as Frontiers in Pharmacology, Human Psychopharmacology Clinical and Experimental, Xenobiotica, International Journal of Biological Macromolecules and Dalton Transactions.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.